S.3362 - A bill to reauthorize and improve the SBIR and STTR programs, and for other purposes. Sponsor: John Kerry / 110th Congress

Title
110th Congress - A bill to reauthorize and improve the SBIR and STTR programs, and for other purposes.
Summary
A bill to reauthorize and improve the SBIR and STTR programs, and for other purposes. (by CRS)
Status
The bill has passed through committee and has been put on a legislative calendar.

Customize

Customize the interests supporting and opposing this bill

To remove an interest, click the Remove button next to its name below this box.

To add an interest, choose one from this list:

To add an interest, click Support or Oppose.

You can share your customized pages with other people by sending them the URL for pages about this bill. Other MAPLight.org users will not see your customizations unless they use the URL you send them. To save your customizations for your next visit, create a free New Account, then Sign In.

Done

Interests who did want this bill to become law included these interests and specific groups:

Interests who did not want this bill to become law included these interests and specific groups:

(None found)

Contribution data provided by the Center for Responsive Politics (OpenSecrets.org)

Comments RSS feed

Revamped SBIR by Peter Volberding, Aug 15, 2008 (5:59pm)

How it is written today, S 3362 is significantly different than the version of the House bill that passed earlier this year. It refines the language and adds a few other provisions that tailor it to better suit the needs of small businesses. The main worry is that large companies, principally venture capital and biotech industries, would be able to exploit small businesses by quietly controlling them with investment, but still reap the benefits from government subsidies. This bill, however, is likely to disappoint at least the biotech industry a little, since the compromise aims to close some of those loopholes. However, this new compromise also is beginning to split small business owners. The National Small Business Association is now at odds with the American Small Business League because the NSBA sees the compromise as workable. The ASBL vows to continue the fight. Even if the Senate bill passes, it still must be reconciled with the vastly different House version, which heavily favors the biotech and venture capital industries. Regardless, it will be an interesting fight because the SBIR and STTR programs are set to sunset next month.

Reply to this comment
Reply to this comment close
[ Tags ]
[ Tags ] close
[ Spam ]
[ Spam ] close